lymphokine-activated killer cells
CDR0000630437
Phase 2 mab terminated
Quick answer
lymphokine-activated killer cells for Brain and Central Nervous System Tumors is a Phase 2 program (mab) at LISATA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LISATA THERAPEUTICS, INC.
- Indication
- Brain and Central Nervous System Tumors
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated